During the past decade, Laszlo J. Mate, MD conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laszlo J. Mate, MD" #1 sponsor was "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials, followed by "ACADIA Pharmaceuticals Inc." with 2 trials sponsored, "Avanir Pharmaceuticals" with 2 trials sponsored, "Cubist Pharmaceuticals LLC" with 2 trials sponsored and "NEMA Research, Inc." with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laszlo J. Mate, MD" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Laszlo J. Mate, MD" are "Epilepsy, Partial Seizures" (2 trials), "Multiple Sclerosis" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials), "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials) and "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "Laszlo J. Mate, MD" in a lesser frequency.

Most popular intervention types in "Laszlo J. Mate, MD" are "Drug" (16 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cesamet™ (nabilone)" (2 trials), "Pimavanserin" (2 trials), "Pregabalin" (2 trials) and "ADL5747" (1 trials). Other intervention names were less common.

The vast majority of trials in "Laszlo J. Mate, MD" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Laszlo J. Mate, MD". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Laszlo J. Mate, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Laszlo J. Mate, MD, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".